Midland States Bancorp heads into its April 30 Q1 earnings release with options traders turning sharply bullish while short sellers quietly back away.
The most striking positioning signal is the collapse in the put/call ratio. It has fallen to 0.22 — more than a full standard deviation below its 20-day average of 1.41, and close to its 52-week low of 0.06. That's a decisive tilt toward calls, reflecting aggressive demand for upside exposure rather than hedging. The shift coincides with a strong price recovery: MSBI gained 9% on the week and nearly 19% over the past month, closing at $25.84. Most correlated peers — SBSI, FMBH, UVSP — were broadly flat to slightly lower on the week, which makes MSBI's move stand out.
Short interest paints a less threatening picture than the monthly change implies. Although the estimated short position rose roughly 46% over the past month to around 648,000 shares, it remains a modest 3% of the free float — well inside the territory that would suggest meaningful pressure. Utilization doubled from March lows, reaching 3.1%, but that remains far below the 52-week peak of 5.6%. Borrowing costs have actually eased, declining more than 34% over the past month to 0.55% — borrow is cheap and plentiful. Short sellers pared positions sharply on April 24, cutting by more than 8% in one session, suggesting the bears who built during early April are already exiting into the rally.
The fundamental debate centers on whether the bank's NIM expansion and credit quality improvement are durable. Bulls point to a 23-basis-point rise in net interest margin to 3.79% and a 3% dividend increase as evidence that the bank is generating stronger returns from its interest-earning assets. Bears counter that loan volumes are shrinking intentionally — held-for-investment loans fell 3% quarter-over-quarter as management runs off equipment financing and commercial real estate balances, with total deposits also down 6%. Both DA Davidson and Piper Sandler lifted targets on April 27 but kept Neutral ratings, taking targets to $26 and $28 respectively — a tell that the Street acknowledges improved momentum without committing to a buy. The stock's P/E near 8.4x and P/B at roughly 1.1x keep valuation undemanding. Factor scores flag strong EPS momentum at the 92nd percentile over 30 days, and an EPS surprise rank in the 88th percentile, giving bulls further ammunition.
The April 30 print will test whether the NIM gains and credit stabilisation are enough to justify the stock's 47% rebound from its late-2025 lows — or whether the deliberate loan shrinkage and deposit outflows signal a more structurally constrained growth profile than the options market is pricing in.
See the live data behind this article on ORTEX.
Open MSBI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
